Recognizing and Confirming Potential ATTR in Your Patients
Released On
September 01, 2024
Expires On
August 30, 2025
Media Type
Internet
Completion Time
1 Hour
Specialty
Cardiology, Hematology-Oncology, Neonatology, Neurology
Topics
Cardiovascular Disease, Oncology, Heart
This activity is supported in part by an independent education grant from Alexion Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., and AstraZeneca Pharmaceuticals.
Credit Available
- Physicians - maximum of 1.0 AMA PRA Category 1 Credits™
- Nurses - 1.0 Nursing Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation
Target Audience
This activity is designed to meet the educational needs of physicians, allied health practitioners, and students interested in complex cardiovascular and thoracic conditions and those who care for patients with ATTR.
Program Overview
This activity will cover early diagnosis and intervention for transthyretin amyloidosis (ATTR), which is critical, yet does not occur, typically as a consequence of the rarity and heterogeneity of the disease and limited awareness on the part of clinicians. Therapeutic options are limited, but there are new and emerging agents and emerging indications with which clinicians may not be familiar. Access to specialized care centers is limited for many patients, leading to suboptimal management and disease monitoring. This education fills a significant need for healthcare team education to ensure all patients benefit from best practices in recognizing, diagnosing, and managing amyloidosis.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Identify common diagnostic issues for patients with ATTR
- Recognize ATTR genotypes and phenotypes, including typical symptomatology
- Discuss multidisciplinary strategies for confirming ATTR diagnosis
Faculty
Bryan Abadie, MD
Fellow, Department of Cardiovascular Medicine
Cleveland Clinic
Cleveland, OH
Jeremy Brooksbank, MD
Fellow, Department of Cardiovascular Medicine
Cleveland Clinic
Cleveland, OH
Andres Carmona Rubio, MD
Department of Cardiovascular Medicine
Cleveland Clinic
Cleveland, OH
Mazen Hanna, MD
Director of the Heart Failure Intensive Care Unit and Co-Director of the Amyloid Program
Staff cardiologist, Section of Heart Failure and Cardiac Transplantation Medicine
Sydell Arnold Miller Family Heart, Vascular & Thoracic Institute
Cleveland Clinic
Cleveland, OH
Deborah Kwon, MD
Director of Cardiac MRI
Staff cardiologist, Section of Cardiovascular Imaging
Robert and Suzanne Tomsich Department of Cardiovascular Medicine
Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute
Cleveland Clinic
Cleveland, OH
Jason Valent, MD
Hematology and Medical Oncology
Cleveland Clinic
Cleveland, OH
Accreditation Statement
In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation
Cleveland Clinic Center for Continuing Education designates this internet enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
Certificate of Participation
A certificate of participation will be provided to other healthcare professionals for requesting credits in accordance with their professional boards and/or associations.
Disclosures of Conflicts Of Interest
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
Faculty Name
Eric E Roselli, MD: Artivion - Consulting, Teaching, and Speaking. Cook Medical - Teaching and Speaking. Cryolife, Inc. - Consulting. Terumo - Teaching and Speaking. W.L. Gore & Associates - Consulting. Medtronic - Consulting. Edwards Lifesciences - Teaching and Speaking. Abbott - Teaching and Speaking. LivaNova, PLC - Consulting, Teaching, and Speaking
Mazen Hanna, MD: Pfizer - Advisor or review panel participant. Alexion - Advisor or review panel participant. Alnylam - Advisor or review panel participant. Akcea Therapeutics, Inc. - Advisor or review panel participant. Eidos Therapeutics - Advisor or review panel participant
Michael Trejeeve Martyn, MD: Recora Health - Consulting. Synkopi inc. - Consulting. Synkopi Inc. - Consulting. Recora Health - Consulting. Astra Zeneca - Research. Astra Zeneca - Research. Ionis Pharmaceuticals - Research. Ionis Pharmaceuticals -Research. Akcea Therapeutics, Inc. - Research. The Clinic by Cleveland Clinic - Consulting. The Clinic by Cleveland Clinic - Consulting. Fire1 - Consulting. Apricity Robotics - Consulting. Boehringer Ingelheim - Consulting
Jack Khouri, MD: GPCR Therapeutics - Teaching and Speaking, Research. Janssen Pharmaceuticals, Inc. - Consulting, Advisor, or review panel participant
The following faculty have indicated they have no relationship that, in the context of their presentation(s), could be perceived as a potential conflict of interest: Kathleen Breznai; Jeanna Sigmund, MSN; Arianne Clare Agdamag, MD; Andres E Carmona Rubio, MD; Preethi William, MBBS
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME, credit participants must:
- Complete the activity, including any questions or posttest.
- Complete the application for credit, including the evaluation.
- Save your personalized CME certificate.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
Cleveland Clinic requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic. In no event will The Cleveland Clinic be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
Contact Information
For CME questions please contact: [email protected].